Calibre Scientific has acquired RUWAG Handels AG to enhance its product offerings and strengthen its presence in the Swiss diagnostics market.

Information on the Target

Calibre Scientific has announced its acquisition of RUWAG Handels AG, a leading provider of diagnostics and life sciences products and services in Switzerland. RUWAG has been serving various sectors, including hospitals, private labs, universities, and pharmaceutical companies, for over 35 years. The company is recognized for its expertise in infectious diseases, gastroenterology, oncology, autoimmune disorders, and microbiology. In addition to its diagnostic capabilities, RUWAG offers a range of life sciences products such as transfection systems, cells, media, test kits, gene expression systems, and endotoxin testing services.

Furthermore, RUWAG enhances its offerings with robust customer service and support, including maintenance and repair services for instruments, as well as access to an in-house testing laboratory. This strategic alignment with Calibre Scientific is set to leverage RUWAG's comprehensive portfolio and established market presence in the Swiss diagnostics sector.

Industry Overview in Switzerland

Switzerland boasts a sophisticated life sciences industry that thrives on innovation and research. The country is home to a prominent pharmaceutical sector, supported by strong academic institutions and a well-established r